The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study.
Jon T Giles; Justyna Fert-Bober; Jin Kyun Park; Clifton O Bingham; Felipe Andrade; Karen Fox-Talbot; Dimitrios Pappas; Antony Rosen; Jennifer van Eyk; Joan M Bathon; et al. (Profiled Authors: Jon Giles; Jennifer Van Eyk; Felipe Andrade; Marc Halushka; Antony Rosen; Joan Bathon; Dimitrios Pappas; Clifton Bingham)
Division of Rheumatology, Columbia University, College of Physicians & Surgeons, 630 W 168th St, New York, NY 10032 USA. firstname.lastname@example.org
Arthritis research & therapy 2012;14(1):R39.
INTRODUCTION: The aim of this study was to explore the presence and localization of myocardial citrullination in samples from rheumatoid arthritis (RA) patients compared to rheumatic and non-rheumatic disease control groups. METHODS: Archived myocardial samples obtained during autopsy from 1995 to 2009 were assembled into four groups: RA; scleroderma; fatal myocarditis; and non-rheumatic disease controls. Samples were examined by immunohistochemistry (IHC) for the presence and localization of citrullination and peptidyl arginine deiminase enzymes (PADs) by a single cardiovascular pathologist blinded to disease group and clinical characteristics. RESULTS: Myocardial samples from seventeen RA patients were compared with those from fourteen controls, five fatal myocarditis patients, and ten scleroderma patients. Strong citrullination staining was detected exclusively in the myocardial interstitium in each of the groups. However, average and peak anti-citrulline staining was 59% and 44% higher, respectively, for the RA group compared to the combined non-RA groups (P < 0.05 for both comparisons). Myocardial fibrosis did not differ between the groups. In contrast to citrullination, PADs 1 to 3 and 6 were detected in cardiomyocytes (primarily PADs 1 and 3), resident inflammatory cells (primarily PADs 2 and 4), and, to a smaller extent, in endothelial cells and vascular smooth muscle cells. PAD staining did not co-localize with anti-citrulline staining in the interstitium and did not vary by disease state. CONCLUSIONS: Staining for citrullination was higher in the myocardial interstitium of RA compared to other disease states, a finding that could link autoimmunity to the known increase in myocardial dysfunction and heart failure in RA.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Erika Darrah; Antony Rosen; Jon T Giles; Felipe AndradeAnnals of the rheumatic diseases 2012;71(1):92-8.
Philip J Clements; Michael D Roth; Robert Elashoff; Donald P Tashkin; Jonathan Goldin; Richard M Silver; Mildred Sterz; James R Seibold; Dean Schraufnagel; Robert W Simms; et al.Annals of the rheumatic diseases 2007;66(12):1641-7.
Angeliki Asimaki; Harikrishna Tandri; Elizabeth R Duffy; Jeffrey R Winterfield; Shannon Mackey-Bojack; Maria M Picken; Leslie T Cooper; David J Wilber; Frank I Marcus; Cristina Basso; et al.Circulation. Arrhythmia and electrophysiology 2011;4(5):743-52.
Appears in this Publication
Author of this Publication